Skip to content
HowShorted

Intellia Therapeutics, Inc. short interest in 2020

In 2020, Intellia Therapeutics, Inc.'s disclosed short interest ran from 19.54% of shares outstanding on 15 Jan 2020 to 17.18% on 31 Dec 2020, a change of -2.36 percentage points. The year's high was 21.99% on 15 Apr 2020 and its low 17.18% on 31 Dec 2020, averaging 20.36% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 20.00 days on 31 Aug 2020. Full history: Intellia Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Intellia Therapeutics, Inc. in 2020

2020 in figures

Start of year
19.54% (15 Jan 2020)
End of year
17.18% (31 Dec 2020)
Change
-2.36 pp
High
21.99% (15 Apr 2020)
Low
17.18% (31 Dec 2020)
Average
20.36%
Highest days to cover
20.00 (31 Aug 2020)
SEC filings marked
9

Every report in 2020

Intellia Therapeutics, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 202019.54%18.23results (8-K)
31 Jan 202020.86%19.04
14 Feb 202021.24%18.40
28 Feb 202021.52%13.6310-K filed, results (8-K)
13 Mar 202021.80%10.60
31 Mar 202021.31%13.72
15 Apr 202021.99%19.66
30 Apr 202021.20%17.13
15 May 202020.64%13.3810-Q filed, results (8-K)
29 May 202021.04%11.74
15 Jun 202019.52%6.81
30 Jun 202021.76%12.01
15 Jul 202020.79%12.60
31 Jul 202018.34%19.69
14 Aug 202018.66%15.9610-Q filed, results (8-K)
31 Aug 202018.53%20.00
15 Sep 202018.99%14.44
30 Sep 202020.32%15.38
15 Oct 202021.78%10.33
30 Oct 202021.81%15.05
13 Nov 202021.31%15.4910-Q filed, results (8-K)
30 Nov 202019.80%13.55
15 Dec 202018.69%6.31
31 Dec 202017.18%5.64

See also: Intellia Therapeutics, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.